This Funding Opportunity Announcement (FOA) is a part of NIDA’s Racial Equity Initiative (REI).This FOA invites R01 applications to conduct research that will have a major impact in identifying, developing, implementing, or testing strategies to improve outcomes related to substance misuse, with a goal of preventing, reducing, or eliminating disparities in racial and ethnic minority populations in substance use, addiction, and related health consequences, including HIV.
Donor Name: National Institutes of Health
State: All states
County: All Counties
Territory: Commonwealth of Puerto Rico, U.S. Virgin Islands, Guam, American Samoa, Commonwealth of the Northern Mariana Islands
Type of Grant: Grant
Deadline: 11/14/2024
Size of the Grant: $2 million
Grant Duration: 5 years
Details:
Purpose
This FOA seeks to fund innovative community partnered research by diverse teams that addresses community-driven priorities for reducing disparities in outcomes for racial and ethnic minority populations related to substance use, addiction, and related health consequences including HIV. Research projects should demonstrate that they will have a major impact in improving outcomes related to substance misuse, with a goal of identifying or targeting strategies to prevent, reduce, or eliminate racial and/or ethnic disparities in substance use outcomes.
The NIH is committed to supporting health equity research to 1) improve minority health and reduce health disparities in the United States and 2) remove the barriers to advancing health disparities research (for more information, see: NIH’s statement on ending structural racism and the NIH/NIMHD Strategic Plan). In alignment with this NIH-wide effort, NIDA established the Racial Equity Initiative (REI), with goals that include promoting racial equity in NIDA’s research portfolio. Among the actions taken by NIDA, which were informed by internal and external meetings and listening sessions, the Institute has committed to a significant increase in funding for research to address disparities in outcomes related to drug use and HIV. The REI funding opportunity announcements seek to advance equity by supporting research and research training efforts that are consistent with NIDA’s mission and with best practices for conducting research with racial and ethnic minority populations.
Research Objectives
Responsive research must take place in the United States and propose novel approaches to improving substance misuse related outcomes and decreasing racial and ethnic minority disparities in substance misuse, addiction, and related health outcomes. Research topics should be derived from the priorities and experience of the communities that are partnering in the research and that are expected to benefit from the research. Projects should be designed to solve or inform real world challenges, reflecting first-hand as well as scientific knowledge.
Research topics responsive to this FOA include etiology, prevention, harm reduction, treatment, services (including increasing use of evidence-based prevention or treatment through dissemination and implementation research), and research on medical consequences. Observational or intervention studies focused on etiology will only be considered responsive when investigators demonstrate a need to further understand mechanisms that will inform intervention.
Topics of interest for this FOA include the list below, however applications need not be limited to the topics on this list:
- Etiological studies that identify causal mechanisms that lead to differential patterns of onset of drug use and progression to substance use disorder (SUD) for racial or ethnic minority populations affected by disparities in drug use consequences and treatment utilization. Applications focusing on etiology must describe how the research will be used to inform intervention development and include investigators on the study team with intervention expertise to facilitate translation of research results to intervention research and practice.
- Identifying strategies derived from a structural orientation to mitigate the contribution of implicit and explicit bias, race-based discrimination and microaggressions that contribute to vulnerability to substance use and misuse
- Investigating patterns of access to and utilization of prevention and treatment services, including understanding and intervening to address stigma, mistrust, financial barriers, location, and other barriers described by research participants, community members or other stakeholders.
- Addressing bias within the educational and juvenile justice systems, including research on the impact of differential treatment on risk for poor outcomes related to drug use and drug involvement.
- Testing novel prevention or treatment interventions, or adapting existing interventions to make them more culturally specific or implementable within a specific service system (e.g., justice, child welfare, primary care)
Funding Information
- NIDA intends to commit approximately $2 million total in FY 2023 for this initiative.
- The maximum project period is 5 years.
Eligibility Criteria
- Higher Education Institutions
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
- To be eligible for this FOA, the applicant institution must be a domestic institution located in the United States and its territories which:
- has received less than $25 million dollars per year (total costs) from NIH Research Project Grants (RPGs) in each of the preceding two fiscal years, calculated using NIH RePORTER; and
- award graduate degrees in biomedical sciences; and
- has a historical and current mission to educate students from any of the populations that have been identified as underrepresented in biomedical research as defined by the National Science Foundation NSF, (i.e., African Americans or Blacks, Hispanic or Latino Americans, American Indians, Alaska Natives, Native Hawaiians, U.S. Pacific Islanders, and persons with disabilities) or has a documented record of: (1) recruiting, training and/or educating, and graduating underrepresented students as defined by NSF (see above), which has resulted in increasing the institution’s contribution to the national pool of graduates from underrepresented backgrounds who pursue biomedical research careers and, (2) for institutions that deliver health care services, providing clinical services to medically underserved communities. To demonstrate eligibility for this FOA, applicants are required to provide specific details addressing criterion #3 above as a part of a single attachment entitled “Institutional Information.” Applications that do not include sufficient evidence of eligibility may be administratively withdrawn.
For more information, visit Grants.gov.
